Trials / Conditions / CD20-positive B-cell Non-Hodgkin Lymphoma
CD20-positive B-cell Non-Hodgkin Lymphoma
3 registered clinical trials studyying CD20-positive B-cell Non-Hodgkin Lymphoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | A Phase 1 Study of TRS005 in Patients With R/R CD20-positive B-NHL. NCT05395533 | Zhejiang Teruisi Pharmaceutical Inc. | Phase 1 |
| Completed | A Study of MIL62 in Treatment of CD20 Positive B-cell Lymphomas NCT04103905 | Beijing Mabworks Biotech Co., Ltd. | Phase 1 |
| Completed | A Study Combining Ibrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Pati NCT01569750 | Janssen Research & Development, LLC | Phase 1 |